CODEXIS INC. - COMMON

Codexis Announces New Employment Inducement Grants

15 2 2023 16:05:00 提供 Nasdaq GlobeNewswire

Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23

09 2 2023 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Announces Appointment of Sri Ryali as Chief Financial Officer

23 1 2023 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Announces Appointment of H. Stewart Parker to Board of Directors

20 12 2022 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Provides Update on Prioritized Corporate Strategy

29 11 2022 16:05:00 提供 Nasdaq GlobeNewswire

Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference

16 11 2022 16:05:00 提供 Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Healthcare Conferences

08 11 2022 16:05:01 提供 Nasdaq GlobeNewswire

Codexis Reports Third Quarter 2022 Financial Results

03 11 2022 16:05:02 提供 Nasdaq GlobeNewswire

Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel

01 11 2022 08:00:03 提供 Nasdaq GlobeNewswire

Codexis to Report Third Quarter 2022 Financial Results on November 3

20 10 2022 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer

03 10 2022 08:00:02 提供 Nasdaq GlobeNewswire

Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors

03 10 2022 08:00:01 提供 Nasdaq GlobeNewswire

Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field

14 9 2022 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Reports Second Quarter 2022 Financial Results

04 8 2022 16:05:01 提供 Nasdaq GlobeNewswire

Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis

02 8 2022 16:05:01 提供 Nasdaq GlobeNewswire

Codexis Announces CEO Transition Effective August 9, 2022

18 7 2022 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)

14 7 2022 16:06:00 提供 Nasdaq GlobeNewswire

Codexis Announces Preliminary Second Quarter 2022 Results and Updates Guidance

14 7 2022 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native Peptides

17 6 2022 08:00:00 提供 Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Healthcare Conferences

25 5 2022 16:05:00 提供 Nasdaq GlobeNewswire